Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Steroid Biochemistry and Molecular Biology|September 23, 1998
Control of the proliferation of prostate cancer cells by an androgen and two antiandrogens. Cell specific sets of responsesO Foury, B Nicolas, M O Joly-Pharaboz, et al.
Nuclear Medicine and Biology|April 1, 1994
Heterogeneity of human prolactin. Influence on immunoassays (RIA and IRMA)B Claustrat, J Brun, J Champier, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 10, 2001
Haemodialysis with the biocompatible high permeability AN-69 membrane does not alter plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3J Bohé, M O Joly, W Arkouche, et al.
Calcified Tissue International|July 17, 2004
Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age: MINOS studyP Szulc, M O Joly-Pharaboz, F Marchand, et al.
Journal of Steroid Biochemistry|January 1, 1988
Inhibition of the MtTF4 tumor growth by dexamethasoneM O Joly-Pharaboz, V Albaladejo, Y Morel, et al.
Journal of Steroid Biochemistry|January 1, 1989
Size heterogeneity of affinity labeled estrogen receptors in the MtTF4 tumor whose growth is inhibited by estradiol, in pituitary gland and uterusB Bouillard, V Albaladejo, M O Joly-Pharaboz, et al.
Mineral and Electrolyte Metabolism|April 29, 1998
Effects of recombinant growth factors on energy expenditure in maintenance hemodialysis patientsA Tabakian, L Juillard, M Laville, et al.
Cancer Letters|July 10, 1992
The control by estradiol of pituitary tumor and cell growth is not correlated with that of kallikrein gene expressionE Faurobert, V Albaladéjo, M O Joly-Pharaboz, et al.
Pageof 3